Point-of-care lung ultrasound, lung CT and NEWS to predict adverse outcomes and mortality in COVID-19 associated pneumonia
Introduction: The appraisal of disease severity and prediction of adverse outcomes using
risk stratification tools at early disease stages is crucial to diminish mortality from coronavirus …
risk stratification tools at early disease stages is crucial to diminish mortality from coronavirus …
Exploring m6A‐RNA methylation as a potential therapeutic strategy for acute lung injury and acute respiratory distress syndrome
Abstract N6‐methyladenosine (m6A) is the most common methylation modification in
mammalian messenger RNA (mRNA) and noncoding RNAs. m6A modification plays a role …
mammalian messenger RNA (mRNA) and noncoding RNAs. m6A modification plays a role …
[HTML][HTML] Practice of 18F-FDG-PET/CT in ICU patients: a systematic review
18 F-FDG-PET/CT imaging has become a key tool to evaluate infectious and inflammatory
diseases. However, application of 18 F-FDG-PET/CT in patients in the intensive care unit …
diseases. However, application of 18 F-FDG-PET/CT in patients in the intensive care unit …
[HTML][HTML] Activating transcription factor 6 in the endothelial context
N Barabutis - Pulmonary Pharmacology & Therapeutics, 2023 - ncbi.nlm.nih.gov
Acute Respiratory Distress Syndrome (ARDS) is the cause of thousands of deaths in the
intensive care units, since efficient therapies for that disorder do not exist. Herein, and based …
intensive care units, since efficient therapies for that disorder do not exist. Herein, and based …
[HTML][HTML] Respiratory failure
Respiratory Failure - StatPearls - NCBI Bookshelf US flag An official website of the United States
government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI …
government Here's how you know NIH NLM Logo Access keys NCBI Homepage MyNCBI …
[HTML][HTML] Identifying vital sign trajectories to predict 28-day mortality of critically ill elderly patients with acute respiratory distress syndrome
M Li, F Liu, Y Yang, J Lao, C Yin, Y Wu, Z Yuan… - Respiratory …, 2024 - Springer
Background The mortality rate of acute respiratory distress syndrome (ARDS) increases with
age (≥ 65 years old) in critically ill patients, and it is necessary to prevent mortality in elderly …
age (≥ 65 years old) in critically ill patients, and it is necessary to prevent mortality in elderly …
[HTML][HTML] An acute respiratory distress syndrome drug development collaboration stimulated by the Virginia Drug Discovery Consortium
JS Lazo, RML Colunga-Biancatelli, PA Solopov… - Slas Discovery, 2023 - Elsevier
The genesis of most older medicinal agents has generally been empirical. During the past
one and a half centuries, at least in the Western countries, discovering and developing …
one and a half centuries, at least in the Western countries, discovering and developing …
[HTML][HTML] Pneumonia and Related Conditions in Critically Ill Patients—Insights from Basic and Experimental Studies
DA Kashatnikova, MB Khadzhieva… - International Journal of …, 2022 - mdpi.com
Pneumonia is an acute infectious disease with high morbidity and mortality rates.
Pneumonia's development, severity and outcome depend on age, comorbidities and the …
Pneumonia's development, severity and outcome depend on age, comorbidities and the …
Differential changes in expression of inflammatory mRNA and protein after oleic acid-induced acute lung injury
R Golding, RK Braun, L Miller, M Lasarev… - Experimental Lung …, 2024 - Taylor & Francis
Abstract Background: Acute Respiratory Distress syndrome (ARDS) is a clinical syndrome of
noncardiac pulmonary edema and inflammation leading to acute respiratory failure. We …
noncardiac pulmonary edema and inflammation leading to acute respiratory failure. We …
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID‐19: An open‐label trial
G Poulakou, M Barakat, RJ Israel… - Clinical and …, 2023 - Wiley Online Library
There is an unmet medical need for effective treatments for hospitalized patients with
coronavirus disease 2019 (COVID‐19). Ribavirin is a broad‐spectrum antiviral with …
coronavirus disease 2019 (COVID‐19). Ribavirin is a broad‐spectrum antiviral with …